Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Creatine doesn't directly cause fat loss or fat gain
Research Applications Dual Incretin Pharmacology GIP+GLP-1R co-agonism, receptor interaction, GIPR adipose signalling T2D Research SURPASS program up to 2.58% HbA1c reduction vs placebo Obesity Models SURMOUNT-1: 22.5% weight reduction (15mg, 72 weeks) NASH/Liver SYNERGY-NASH: 62.4% NASH resolution at 10mg vs Semaglutide Head-to-head SURMOUNT-5 reference compound Quick Specs Certificate of Analysis (COA) Frequently Asked Questions How do I reconstitute Tirzepatide
Personalized Treatments We understand that weight and its relationship to your health is a personal, complex topic
A consultation helps determine if its the right treatment for your goals
Shaw will let you know what to expect from the medication once your goals are evaluated in a consultation
A class of weight-loss drugs known as glucagon-like peptide-1s (GLP-1s for short) has proven effective, including for Medicare-age people 65 and up, according a meta-analysis by Johns Hopkins University researchers as well as other studies